TSE Co Ltd

TSE Co Ltd maintains a strong liquidity position with KRW 75.8 billion in cash and equivalents, supported by a current ratio of 2.77. The company's price-to-book ratio of 6.43 and price-to-tangible-book ratio of 6.43 indicate a premium valuation relative to its book value. A debt-to-equity ratio of 0.12 suggests a conservative capital structure with limited leverage.

Profitability metrics show a return on equity of 9.77% and return on assets of 6.29%, both below the industry median for Semiconductor Equipment & Testing. The company's operating margin of 11.7% (calculated from operating income of KRW 50.3 billion on revenue of KRW 428.9 billion) lags behind the sector average. Gross margin of 28% (KRW 120.1 billion gross profit on KRW 428.9 billion revenue) reflects competitive pricing pressures in the testing equipment market.

Geographic and segment exposure is not disclosed in the available data, but the company's revenue concentration in semiconductor testing equipment suggests vulnerability to cyclical demand shifts in the broader semiconductor industry. No material geographic diversification is evident from the financial snapshot.

The company's revenue of KRW 428.9 billion represents a 12.3% year-over-year increase, but the outlook for the current fiscal year shows a projected 4.1% decline in revenue. Analysts have issued a mean price target of KRW 130,000, significantly below the current market price of KRW 227,500, suggesting bearish sentiment. The price-to-earnings ratio of 65.83 and EV/EBITDA of 49.39 indicate a high valuation relative to earnings and cash flow.

Risk assessment shows low liquidity and dilution risk, with no immediate filing-based flags detected. The company's free cash flow of KRW 16.3 billion and operating cash flow of KRW 48.6 billion support its liquidity position. No dilution sources were identified in the available documents, and the dilution near-term probability is assessed as low.

Recent events include the publication of Q4 2023 financial results showing a 12.3% revenue increase year-over-year, but analysts have issued a mean recommendation of 1.5 (between strong buy and market outperform) with a median price target of KRW 130,000. No material regulatory or geopolitical risks were identified in the available data.